- Entry
- $11.26
- Now
- $11.16 -0.9%
- Target
- —
- Score
- —
NVAX offers an attractive short-squeeze setup, with roughly 55\*\*% of its float sold short\*\* and about **9 days to cover**. Strong upward momentum and elevated volume could force additional short covering. **Sanofi COVID/flu combination vaccine — potentially the biggest near-term catalyst.** Sanofi is in advanced discussions with regulators on the timing of a Phase 3 COVID/flu combination trial. **Starting that Phase 3 trial would trigger a $125 million milestone payment to Novavax.** There is another potential **$225 million launch milestone** …
— ORIGINAL POST ·
$NVAX offers a great short squeeze opportunity with SI at 55% and a high volume breakout - it take 9 days to cover!!
· r/Shortsqueeze
· Oct 5, 2026